Last Updated：2025/11/25
After promising results in the trial, the oncology team decided to include lexatumumab in the combination therapy regimen.
See correct answer
After promising results in the trial, the oncology team decided to include lexatumumab in the combination therapy regimen.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
